{"id":"W2911174524","doi":"10.1158/1078-0432.ccr-18-3325","title":"Postprogression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-mutated Advanced Non–Small Cell Lung Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; Gefitinib; Internal medicine; Erlotinib; T790M; Hazard ratio; Lung cancer; Oncology; Erlotinib Hydrochloride; Tyrosine-kinase inhibitor; Performance status; Epidermal growth factor receptor; Confidence interval; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005137073,0.0002819298,0.0009298655,0.0002308042,0.0001151244,0.00002673855,0.0002264914,0.0002105204,0.0003092714],"category_scores_gemma":[0.0002686874,0.0001912881,0.0001970975,0.0006598281,0.0001874848,0.0001187318,0.00009805129,0.0005674524,0.00001236415],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001177838,"about_ca_system_score_gemma":0.002091891,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007480595,"about_ca_topic_score_gemma":0.001097683,"domain_scores_codex":[0.9966714,0.0001730266,0.0008036978,0.0007548008,0.0008283732,0.0007686403],"domain_scores_gemma":[0.9961764,0.0009079271,0.0002565789,0.0005654616,0.001779818,0.0003137645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05153014,0.0006417629,0.9169465,0.0009379098,0.0003573116,0.00001015669,0.0007340385,0.0001294835,0.00003964879,0.00000704257,0.000324972,0.02834098],"study_design_scores_gemma":[0.1040854,0.02080099,0.8652087,0.002890868,0.0006661671,1.725939e-7,0.0008433943,0.0002438548,0.002068448,0.00001180764,0.002804667,0.0003755092],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882358,0.00273959,0.000007382404,0.0006408027,0.0005209813,0.00670318,0.0003999114,0.00003945849,0.0007129362],"genre_scores_gemma":[0.9958505,0.0005603308,0.0007250443,0.00009478209,0.00007158361,0.001278918,0.0003348346,0.00008302377,0.001000976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0525553,"threshold_uncertainty_score":0.7800503,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0551726375942707,"score_gpt":0.5012714979434845,"score_spread":0.4460988603492138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}